
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff.
Page template : index.php Search terms : Sort : Page :
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff.
In recognition of Rare Disease Day, CHÉOS Scientist Dr. Larry Lynd shares an insight into his work investigating the diagnosis, treatment, and management of rare diseases
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
As Dr. Amy Salmon continues to navigate the long-lasting effects of the virus, she is appreciative of the unique perspective it has brought to her work.
CHÉOS Project Manager Judy Needham recently accepted an award on behalf of the CRPBC. We spoke with Judy to learn more about the CRPBC and the award
CHÉOS Scientist Dr. Sarah Munro investigated what factors influence shared decision-making between care providers and parents-to-be who have previously undergone a C-section
Paramedics are the focus of a new COVID-19 study, led by CHÉOS Scientist Dr. Brian Grunau
As scientists around the world, including a team at St. Paul’s Hospital, are racing to find an effective treatment for COVID-19, CHÉOS project managers are proud to be a small part of this global effort.
To mark Bell Let’s Talk Day, we’re focusing on mental health research from CHÉOS Scientists Drs. Chris Richardson, Anne Gadermann, Rob Stenstrom, and Joseph Puyat
As we enter into another exciting year of improving health outcomes for B.C. and beyond, we’re reflecting on some of the CHÉOS research from the past year